Guardado OCR, Elías-Calles LC, Ramírez LJA

Language: Spanish
References: 10
Page: 75-78
PDF size: 260.81 Kb.

ABSTRACT

Introduction: Despite the progress made in the diagnosis and treatment of dyslipidemias, therapeutic goals are often not reached due to noncompliance of medical indications by some patients or to the presence of adverse reactions to lipid lowering drugs. The use of the BioAlberic method can be another therapeutic alternative.
Objective: To assess the effectiveness of the method in the treatment of hypercholes- terolemia.
Method: A controlled, randomized, open-label pilot study was designed. The sample was composed of 60 patients with hypercholesterolemia. Patients were divided into three groups of 20 each: group I treated with coltricé 1, Group II treated with coltricé 2 and group III to whom 20 mg of atorvastatin were administered. Treatment consisted of the oral administration of the BioAlberic product, used in drinking water over a period of 90 days, with a monthly monitoring. At the beginning of the research the serum levels of cholesterol, triglycerides, glutamic pyruvic transaminase and oxaloacetic, uric acid, creatinine, and glucose were determined. Total plasma cholesterol and triglycerides were assessed monthly for three months, and levels at the beginning and end of the research were compared.
Results: Cholesterol was normalized in 12 patients with the use of coltricé (between 9.6 and 6.02 mmol / L), 11 reached borderline levels (from 10.43 to 5.9 mmol / L) and there was no response in 17.
Conclusions: Administration of coltricé could be another therapeutic option in the treatment of hypercholesterolemia.

REFERENCES

1. Nasiff Hadad A, Pérez Pérez LM. Primer Consenso Nacional de Dislipoproteinemias: Guía para la pre-vención, detección, diagnóstico y tratamiento. Rev Cubana Endocrinol [Internet]. 2006 [citado 2013 May 12];17(Supl Especial):[aprox. 41 p.]. Disponible en: http://www.bvs.sld.cu/revistas/end/vol17_4_06/end01406.htm

2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Eva-luation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Cir-culation. 2002;106(25):3143-421.

3. Girotra S, Murarka S, Migrino RQ. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Panminerva Med. 2012;54(2):71-81.

4. Vasudevan AR, Hamirani YS, Jones PH. Safety of statins: effects on muscle and the liver. Cleve Clin J Med. 2005;72(11):990-3, 996-1001.

5. Ramírez JA. El método BioAlberic: origen, desarro-llo y aplicación en el control de los factores de riesgo cardiovascular. CorSalud [Internet]. 2013 [ci-tado 2013 May 10];5(2):150-4. Disponible en:

6. http://bvs.sld.cu/revistas/cors/pdf/2013/v5n2a13/es/bioalberic-des.pdf

7. Ramírez JA, Velázquez H. Empleo de la acupuntura y la auriculopuntura en la recuperación funcional de paciente intervenido por gonartrosis bilateral. XII Congreso Cubano de Reumatología; 12-15 Dic 2007. La Habana: CIMEQ; 2007.

8. Hugues B, González D, Ramírez JA, Álvarez A, Olano R, Pérez L, et al. Utilidad del método BioAlberic en el tratamiento de las hiperlipidemias y la obesidad en caninos domésticos. CorSalud [Internet]. 2013 [citado 2013 May 10];5(2):212-6. Disponible en: http://bvs.sld.cu/revistas/cors/pdf/2013/v5n2a13/es/bioalberic-lipidos.pdf

9. Sandoval MH, Barrón HJ, Loli RA, Salazar YV. Pre-cisión en la determinación de glucosa, colesterol y triglicéridos séricos, en laboratorios clínicos de Lima, Perú. An Fac Med. 2012;73(3):233-8.

10. Schettler G, Nüssel E. Triglycerides liquicolor GPO-PAP. Arb Med Loz Med Präv Med. 1975;10:25.